The Clinical Decision Support Scoring System can estimate with high accuracy the histological status of women attending for cytology-based screening.
Artificial neural networks improve the prediction of CIN2 or worse when compared with cytology and/or HPV DNA test.
The Clinical Decision Support Scoring System can optimise the personalised management of women with abnormalities at cervical screening.